...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Developmentally modulated cardiac conduction failure in transgenic mice with fetal or postnatal overexpression of DNA nonbinding mutant Nkx2.5.
【24h】

Developmentally modulated cardiac conduction failure in transgenic mice with fetal or postnatal overexpression of DNA nonbinding mutant Nkx2.5.

机译:胎儿或出生后DNA非结合突变体Nkx2.5过表达的转基因小鼠的发育调节性心脏传导衰竭。

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: Nkx2.5 is a conserved homeodomain (HD) containing transcription factor essential for early cardiac development. We generated a DNA nonbinding missense mutation, I183P in the HD, similar to the missense HD mutation found in patients. Transgenic mice expressing this mutation under beta-MHC promoter [beta-MHC(I183P)] showed a postnatal lethal phenotype with heart failure. In contrast, mice expressing the mutation under alpha-MHC promoter [alpha-MHC(I183P)] survive, with later onset heart failure. The aim of this study was to investigate the interrelationship between lethal cardiac failure and the electrophysiologic (EP) phenotypes using cardiac-specific promoters with mutant gene expression at different stages of development and maturation. METHODS AND RESULTS: In beta-MHC(I183P) and wild-type littermates, six-lead ECG and in vivo endocardial EP studies were performed at 2.5, 3, 4, and 5 weeks of age. In alpha-MHC(I183P) and their wild-type controls, ECGs were acquired at 3, 19, 31, and 64 weeks and in vivo EP studies assessed at 19 +/- 4 weeks of age. Beta-MHC(I183P) mice display AV nodal, atrial, and ventricular EP dysfunction by 3 weeks of age. Bradycardia and PR prolongation were evident on telemetered ambulatory ECG of beta-MHC(I183P) mice. In contrast, alpha-MHC(I183P) mice had no abnormalities on serial ECG through 31 weeks or EP findings at 19 weeks, except increased myocardial tissue refractoriness. However, by 64 weeks, PR intervals lengthened in alpha-MHC(I183P) mice. CONCLUSION: Both prenatal and postnatal overexpression of DNA nonbinding mutant Nkx2.5 are associated with AV conduction malfunction and heart failure; however, more profound progressive EP defects are seen when this mutation expresses during fetal and neonatal periods. These conduction abnormalities may contribute to the lethal heart failure and early mortality evident in DNA nonbinding mutant Nkx2.5 mice.
机译:简介:Nkx2.5是一个保守的同源域(HD),其中包含早期心脏发育所必需的转录因子。我们在HD中产生了DNA非结合性错义突变I183P,类似于在患者中发现的错义HD突变。在β-MHC启动子[β-MHC(I183P)]下表达此突变的转基因小鼠表现出具有心力衰竭的产后致死表型。相反,在α-MHC启动子[α-MHC(I183P)]下表达突变的小鼠存活下来,随后出现心力衰竭。这项研究的目的是研究在发展和成熟的不同阶段使用具有突变基因表达的心脏特异性启动子来研究致命性心力衰竭与电生理(EP)表型之间的相互关系。方法和结果:在β-MHC(I183P)和野生型同窝仔中,分别在2.5、3、4、5周龄进行了六导ECG和体内心内膜EP研究。在alpha-MHC(I183P)及其野生型对照中,在3、19、31和64周时获得了ECG,并在19 +/- 4周龄时评估了体内EP研究。 Beta-MHC(I183P)小鼠在3周龄之前出现AV淋巴结,心房和心室EP功能障碍。在遥测的β-MHC(I183P)小鼠动态ECG上,心动过缓和PR延长很明显。相比之下,α-MHC(I183P)小鼠在31周内连续ECG或19周EP表现均无异常,但心肌组织耐火性增加。但是,到64周,PR间隔延长了alpha-MHC(I183P)小鼠。结论:DNA非结合突变体Nkx2.5的产前和产后过表达均与房室传导障碍和心力衰竭有关。但是,当这种突变在胎儿和新生儿期表达时,就会看到更严重的进行性EP缺陷。这些传导异常可能导致致命的心力衰竭和DNA非结合型突变Nkx2.5小鼠中明显的早期死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号